
Sign up to save your podcasts
Or


In this podcast, expert clinicians will discuss practice-based advances that may improve the consistent use of pre-exposure prophylaxis.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDisease6
In this podcast, expert clinicians will discuss the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence to prescribed regimens.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E5
In this podcast, expert clinicians will discuss the management of patients with HIV who are highly treatment-experienced.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E4
In this podcast, expert clinicians will discuss how to incorporate individualized ART regimens to improve outcomes in patients with HIV and comorbidities.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E3
In this podcast, expert clinicians will discuss current and prospective use of 2-drug regimens in the treatment of HIV.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E2
In this podcast, expert clinicians will discuss recent guideline revisions regarding the use of ART in different patient populations.
For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E1
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of six podcasts. The faculty of this program will explore various aspects of HIV management, including recent guideline revisions, use of 2-drug regimens, individualizing ART regimens in patients with HIV and comorbidities, as well as the management of patients with HIV who are highly treatment-experienced. In addition, the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence as well as advances in pre-exposure prophylaxis are examined.
From the publisher's feed